Approval · Notice of Compliance 10601 · 2009
VOLTAREN: Notice of Compliance 10601
Issued September 18, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10601
- Date
- September 18, 2009
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph - Class Labelling as per TPD letter of September 10, 2008
- Therapeutic class
- Nonsteroidal Anti-Inflammatory Drug
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VOLTAREN | Not yet assigned | — |
| VOLTAREN SR | Not yet assigned | — |
Medicinal ingredients
- DICLOFENAC SODIUM 50 MG per TAB
- DICLOFENAC SODIUM 50 MG per SUP
- DICLOFENAC SODIUM 100 MG per SUP
- DICLOFENAC SODIUM 75 MG per TAB
- DICLOFENAC SODIUM 100 MG per TAB